Patents/Assignees

Procella Therapeutics AB

2 patents in portfolio

US12404488utility2025
Use of Neuropilin-1 (NRP1) as a Cell Surface Marker for Isolating Human Cardiac Ventricular Progenitor Cells
0 cites
US11725244utility2023
Genetic Markers for Engraftment of Human Cardiac Ventricular Progenitor Cells
0 cites